1. Introduction 1. Research Scope 2. Market Segmentation 3. Research Methodology 4. Definitions and Assumptions 2. Executive Summary 3. Market Dynamics 1. Market Drivers 2. Market Restraints 3. Market Opportunities 4. Key Insights 1. New Product Launch 2. Pipeline Analysis 3. Overview of Challenges Faced in the Antiepileptic Drugs Market 4. Prevalence of Epilepsy - By Key Countries, 2018 5. Key Industry Developments - Mergers, Acquisitions, and Partnerships 5. Global Antiepileptic Drugs Market Analysis, Insights and Forecast, 2015-2026 1. Key Findings / Summary 2. Market Analysis, Insights and Forecast – By Drug Generation 1. First Generation 2. Second Generation 3. Third Generation 3. Market Analysis, Insights and Forecast – By Distribution Channel 1. Hospital Pharmacies 2. Retail Pharmacies 3. Online Pharmacies 4. Market Analysis, Insights and Forecast – By Geography 1. North America 2. Europe 3. Asia pacific 4. Latin America 5. Middle East & Africa 6. North America Antiepileptic Drugs Market Analysis, Insights and Forecast, 2015-2026 1. Key Findings / Summary 2. Market Analysis, Insights and Forecast – By Drug Generation 1. First Generation 2. Second Generation 3. Third Generation 3. Market Analysis, Insights and Forecast – By Distribution Channel 1. Hospital Pharmacies 2. Retail Pharmacies 3. Online Pharmacies 4. Market Analysis, Insights and Forecast – By Country 1. U.S. 2. Canada 7. Europe Antiepileptic Drugs Market Analysis, Insights and Forecast, 2015-2026 1. Key Findings / Summary 2. Market Analysis, Insights and Forecast – By Drug Generation 1. First Generation 2. Second Generation 3. Third Generation 3. Market Analysis, Insights and Forecast – By Distribution Channel 1. Hospital Pharmacies 2. Retail Pharmacies 3. Online Pharmacies 4. Market Analysis, Insights and Forecast – By Country/Sub-region 1. U.K. 2. Germany 3. France 4. Spain 5. Italy 6. Scandinavia 7. Rest of Europe 8. Asia Pacific Antiepileptic Drugs Market Analysis, Insights and Forecast, 2015-2026 1. Key Findings / Summary 2. Market Analysis, Insights and Forecast – By Drug Generation 1. First Generation 2. Second Generation 3. Third Generation 3. Market Analysis, Insights and Forecast – By Distribution Channel 1. Hospital Pharmacies 2. Retail Pharmacies 3. Online Pharmacies 4. Market Analysis, Insights and Forecast – By Country/Sub-region 1. Japan 2. China 3. India 4. Australia 5. Southeast Asia 6. Rest of Asia Pacific 9. Latin America Antiepileptic Drugs Market Analysis, Insights and Forecast, 2015-2026 1. Key Findings / Summary 2. Market Analysis, Insights and Forecast – By Drug Generation 1. First Generation 2. Second Generation 3. Third Generation 3. Market Analysis, Insights and Forecast – By Distribution Channel 1. Hospital Pharmacies 2. Retail Pharmacies 3. Online Pharmacies 4. Market Analysis, Insights and Forecast – By Country/Sub-region 1. Brazil 2. Mexico 3. Rest of Latin America 10. Middle East & Africa Antiepileptic Drugs Market Analysis, Insights and Forecast, 2015-2026 1. Key Findings / Summary 2. Market Analysis, Insights and Forecast – By Drug Generation 1. First Generation 2. Second Generation 3. Third Generation 3. Market Analysis, Insights and Forecast – By Distribution Channel 1. Hospital Pharmacies 2. Retail Pharmacies 3. Online Pharmacies 4. Market Analysis, Insights and Forecast – By Country/Sub-region 1. GCC Countries 2. South Africa 3. Rest of Middle East & Africa 11. Competitive Analysis 1. Key Industry Developments 2. Global Market Share Analysis (2018) 3. Competition Dashboard 4. Comparative Analysis – Major Players 5. Company Profiles (Overview, Products & Services, SWOT Analysis, Recent Developments, Strategies, Financials (Based on Availability)) 1. Pfizer Inc. 1. Overview, 2. Products & Services, 3. SWOT Analysis, 4. Recent Developments, 5. Strategies, 6. Financials (Based on Availability) 2. UCB S.A. 1. Overview, 2. Products & Services, 3. SWOT Analysis, 4. Recent Developments, 5. Strategies, 6. Financials (Based on Availability) 3. GlaxoSmithKline plc. 1. Overview, 2. Products & Services, 3. SWOT Analysis, 4. Recent Developments, 5. Strategies, 6. Financials (Based on Availability) 4. H. Lundbeck A/S 1. Overview, 2. Products & Services, 3. SWOT Analysis, 4. Recent Developments, 5. Strategies, 6. Financials (Based on Availability) 5. Eisai Co., Ltd. 1. Overview, 2. Products & Services, 3. SWOT Analysis, 4. Recent Developments, 5. Strategies, 6. Financials (Based on Availability) 6. Sanofi 1. Overview, 2. Products & Services, 3. SWOT Analysis, 4. Recent Developments, 5. Strategies, 6. Financials (Based on Availability) 7. Sunovion Pharmaceuticals Inc 1. Overview, 2. Products & Services, 3. SWOT Analysis, 4. Recent Developments, 5. Strategies, 6. Financials (Based on Availability) 8. GW Pharmaceuticals plc. 1. Overview, 2. Products & Services, 3. SWOT Analysis, 4. Recent Developments, 5. Strategies, 6. Financials (Based on Availability) 9. Other Prominent Players 1. Overview, 2. Products & Services, 3. SWOT Analysis, 4. Recent Developments, 5. Strategies, 6. Financials (Based on Availability) 12. Strategic Recommendations

Pfizer Inc. UCB S.A. GlaxoSmithKline plc. H. Lundbeck A/S Eisai Co., Ltd. Sanofi Sunovion Pharmaceuticals Inc. GW Pharmaceuticals plc. Other Prominent Players